Understanding Your Mounjaro v Wegovy UK Treatment Options
Prescription Weight Loss: Mounjaro v Wegovy UK Mechanisms
When evaluating Mounjaro v Wegovy UK prescription weight loss options, the fundamental difference lies in their biological mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro uses tirzepatide, a dual-action treatment that targets both GIP and GLP-1 receptors, offering a broader hormonal approach to weight management. Both are prescription-only medicines requiring clinical assessment and work alongside a reduced-calorie diet and increased physical activity. Your prescriber can determine which mechanism may be most suitable for your individual circumstances and medical history.
The weekly injection schedule remains consistent for both treatments, though the dose escalation patterns differ slightly. Wegovy follows a structured 20-week escalation from 0.25mg to the 2.4mg maintenance dose, while Mounjaro has its own titration schedule. Both medications require careful dose progression to minimise gastrointestinal side effects and optimise tolerance. At EverydayMeds, our clinical team provides comprehensive guidance throughout your treatment journey, ensuring you understand the progression timeline for whichever option your prescriber recommends.
Mounjaro v Wegovy UK Pricing and Value Comparison
Understanding the cost structure for Mounjaro v Wegovy UK treatments helps with treatment planning and budgeting. Wegovy pricing at EverydayMeds starts with our Intro Duo bundle (0.25mg & 0.5mg) for £169.99, covering your first 8 weeks of treatment. Individual pens range from £79.99 for the starter 0.25mg dose to £209.99 for the maintenance 2.4mg dose. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, ensuring treatment continuity without frequent reordering.
Mounjaro pricing follows a different structure, though both treatments represent significant investments in your long-term health and wellbeing. The key consideration isn't just the upfront cost but the comprehensive service included: clinical assessment, prescriber review, next-day cold-chain delivery, and ongoing support from our GPhC-registered pharmacy team (#9012878). Both medications are available through the same streamlined process at EverydayMeds, allowing your prescriber to recommend the most appropriate option based on clinical factors rather than cost differences alone.
Clinical Evidence for Mounjaro v Wegovy UK Weight Management
The clinical evidence supporting both treatments in the Mounjaro v Wegovy UK comparison comes from robust trial programmes, though direct head-to-head studies are limited. Wegovy's efficacy was demonstrated in the landmark STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The recent SELECT trial additionally demonstrated a 20% reduction in major cardiovascular events, highlighting broader health benefits beyond weight management.
Mounjaro's clinical programme has shown promising results in its own trial settings, though different study designs and populations make direct percentage comparisons inappropriate. Both treatments have received MHRA approval and NICE recommendations for their respective licensed indications. Your prescriber will consider the full clinical picture, including your medical history and treatment goals, when discussing which option may be most suitable for your circumstances.
How Wegovy Works in the Mounjaro v Wegovy UK Context
Wegovy's mechanism of action centres on GLP-1 receptor activation, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. When you inject Wegovy weekly, it binds to GLP-1 receptors in your brain's appetite control centres, reducing hunger signals and promoting feelings of fullness after eating smaller portions. This hormonal approach addresses the biological drivers of overeating rather than relying solely on willpower. The medication also slows gastric emptying, helping food stay in your stomach longer and extending the sensation of satiety. These combined effects can support meaningful weight loss when used alongside lifestyle modifications, making Wegovy a valuable option in the prescription weight loss landscape.
Streamlined Ordering Process for Mounjaro v Wegovy UK
Accessing either treatment through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review every application within 3 working days (or 24 hours with express review), ensuring appropriate clinical oversight for these prescription-only medicines. Once approved, your medication is dispatched via next-day delivery using specialist cold-chain transport to maintain the required 2-8°C temperature throughout transit. This seamless process eliminates the need for multiple GP appointments or lengthy pharmacy queues while maintaining full clinical safety standards. Our GPhC-registered service (#9012878) provides the same professional standards you'd expect from any UK pharmacy, with the added convenience of discrete home delivery.
Storage and Practical Considerations: Mounjaro v Wegovy UK
Practical storage differences can influence your choice in the Mounjaro v Wegovy UK comparison, particularly if you travel frequently or live in variable temperature conditions. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both require refrigeration at 2-8°C for long-term storage and use the convenient pre-filled FlexTouch pen system for weekly injections. The dose escalation schedule for Wegovy spans 20 weeks to reach the maintenance 2.4mg dose, requiring careful progression to optimise tolerance and minimise side effects. Each pen contains four weekly doses, and the injection process takes just seconds once you're familiar with the technique.
Treatment Decision Framework for Mounjaro v Wegovy UK Prescription Weight Loss
Making an informed choice in the Mounjaro v Wegovy UK comparison requires considering multiple factors beyond just the medications themselves. Your prescriber will evaluate your BMI (≥30, or ≥27 with weight-related comorbidities), previous weight loss attempts, current medications, and any contraindications to either treatment. Both options require commitment to lifestyle changes including dietary modifications and increased physical activity - they're treatment aids, not standalone solutions. The medication that works best varies between individuals, and some patients may need to try different approaches before finding their optimal treatment.
At EverydayMeds, we support patients with either choice, providing detailed injection training, storage guidance, and ongoing clinical support throughout your weight management journey. Our prescribers can discuss the specific benefits and considerations of each option based on your individual circumstances, ensuring you make an informed decision that aligns with your health goals and lifestyle requirements.
Start Your Mounjaro v Wegovy UK Assessment Today
Both Mounjaro and Wegovy are available through EverydayMeds' comprehensive prescription weight loss service, with the same high standards of clinical care and convenient home delivery. Our 3-minute assessment opens the door to professional weight management support, with new customers using code FIRST40 and returning customers applying DOSE25 at checkout for the best available pricing. Your treatment choice will be made collaboratively with our qualified prescribers, based on clinical evidence and your individual needs rather than marketing claims. Take the first step towards evidence-based weight management by completing your assessment at https://everydaymeds.co.uk/collections/wegovy - our clinical team is ready to guide you through the decision-making process. With next-day delivery and ongoing support, your prescription weight loss journey can begin as soon as tomorrow.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
